{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:02:14Z","timestamp":1772892134553,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Faroese Research Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary carnitine deficiency (PCD) not treated with L-Carnitine can lead to sudden cardiac death. To our knowledge, it is unknown if asymptomatic patients treated with L-Carnitine suffer from myocardial scarring and thus be at greater risk of potentially serious arrhythmia. Cardiac evaluation of function and myocardial scarring is non-invasively best supported by cardiac magnetic resonance imaging (CMR) with late gadolinium enhancement (LGE). The study included 36 PCD patients, 17 carriers and 17 healthy subjects. A CMR cine stack in the short-axis plane were acquired to evaluate left ventricle (LV) systolic and diastolic function and a similar LGE stack to evaluate myocardial scarring and replacement fibrosis. LV volumes and ejection fraction were not different between PCD patients, carriers and healthy subjects. However, LV mass was higher in PCD patients with the severe homozygous mutation, c.95\u2009A\u2009&gt;\u2009G (p\u2009=\u20090.037; n\u2009=\u200917). Among homozygous PCD patients there were two cases of unexplained myocardial scarring and this is in contrast to no myocardial scarring in any of the other study participants (p\u2009=\u20090.10). LV mass was increased in PCD patients. L-carnitine supplementation is essential in order to prevent potentially lethal cardiac arrhythmia and serious adverse cardiac remodeling.<\/jats:p>","DOI":"10.1038\/s41598-019-50458-9","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T20:12:13Z","timestamp":1569528733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cardiac function and incidence of unexplained myocardial scarring in patients with primary carnitine deficiency - a cardiac magnetic resonance study"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6570-1674","authenticated-orcid":false,"given":"Kasper","family":"Kyhl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00f3ra","family":"R\u00f3in","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Vejlstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Lav","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Engstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"50458_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1196\/annals.1320.004","volume":"1033","author":"CA Stanley","year":"2004","unstructured":"Stanley, C. A. Carnitine deficiency disorders in children. Ann. N. Y. Acad. Sci. 1033, 42\u201351 (2004).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"50458_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1096-7192(02)00169-5","volume":"77","author":"SD Cederbaum","year":"2002","unstructured":"Cederbaum, S. D. et al. Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency. Mol. Genet. Metab. 77, 195\u2013201 (2002).","journal-title":"Mol. Genet. Metab."},{"key":"50458_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10545-013-9606-2","volume":"37","author":"J Rasmussen","year":"2014","unstructured":"Rasmussen, J. et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. J. Inherit. Metab. Dis. 37, 215\u2013222 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"50458_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10545-007-0527-9","volume":"30","author":"AM Lund","year":"2007","unstructured":"Lund, A. M. et al. Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands. J. Inherit. Metab. Dis. 30, 341\u2013349, https:\/\/doi.org\/10.1007\/s10545-007-0527-9 (2007).","journal-title":"J. Inherit. Metab. Dis."},{"key":"50458_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","volume":"56","author":"R O\u2019Hanlon","year":"2010","unstructured":"O\u2019Hanlon, R. et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 56, 867\u2013874, https:\/\/doi.org\/10.1016\/j.jacc.2010.05.010 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50458_CR6","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","volume":"48","author":"RG Assomull","year":"2006","unstructured":"Assomull, R. G. et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J. Am. Coll. Cardiol. 48, 1977\u20131985, https:\/\/doi.org\/10.1016\/j.jacc.2006.07.049 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50458_CR7","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.jacc.2008.03.018","volume":"51","author":"KC Wu","year":"2008","unstructured":"Wu, K. C. et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J. Am. Coll. Cardiol. 51, 2414\u20132421, https:\/\/doi.org\/10.1016\/j.jacc.2008.03.018 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50458_CR8","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.jacc.2006.08.018","volume":"48","author":"CM Kramer","year":"2006","unstructured":"Kramer, C. M. The expanding prognostic role of late gadolinium enhanced cardiac magnetic resonance. J. Am. Coll. Cardiol. 48, 1986\u20131987, https:\/\/doi.org\/10.1016\/j.jacc.2006.08.018 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50458_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ymgmr.2014.04.008","volume":"1","author":"J Rasmussen","year":"2014","unstructured":"Rasmussen, J. et al. Residual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency. Molecular Genetics and Metabolism Reports 1, 241\u2013248 (2014).","journal-title":"Molecular Genetics and Metabolism Reports"},{"issue":"7","key":"50458_CR10","doi-asserted-by":"publisher","first-page":"H1004","DOI":"10.1152\/ajpheart.00309.2013","volume":"305","author":"Kasper Kyhl","year":"2013","unstructured":"Kasper, K. et al. The decrease of cardiac chamber volumes and output during positive-pressure ventilation. American Journal of Physiology-Heart and Circulatory Physiology 305(7), H1004\u2013H1009 (2013).","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"8","key":"50458_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/ehjci\/jev321","volume":"17","author":"Mark Aplin","year":"2016","unstructured":"Mark, A. et al. Cardiac remodelling and function with primary mitral valve insufficiency studied by magnetic resonance imaging. European Heart Journal \u2013 Cardiovascular Imaging 17(8), 863\u2013870 (2016).","journal-title":"European Heart Journal \u2013 Cardiovascular Imaging"},{"key":"50458_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/10976640600572889","volume":"8","author":"AM Maceira","year":"2006","unstructured":"Maceira, A. M., Prasad, S. K., Khan, M. & Pennell, D. J. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 8, 417\u2013426 (2006).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"50458_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ana.410300512","volume":"30","author":"CA Stanley","year":"1991","unstructured":"Stanley, C. A. et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann. Neurol. 30, 709\u2013716 (1991).","journal-title":"Ann. Neurol."},{"key":"50458_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1023\/A:1005371028370","volume":"21","author":"J Sales Marques","year":"1998","unstructured":"Sales Marques, J. Dilated cardiomyopathy caused by plasma membrane carnitine transport defect. J. Inherit. Metab. Dis. 21, 428\u2013429 (1998).","journal-title":"J. Inherit. Metab. Dis."},{"key":"50458_CR15","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1016\/j.ijcard.2012.05.038","volume":"162","author":"A Agnetti","year":"2013","unstructured":"Agnetti, A., Bitton, L., Tchana, B., Raymond, A. & Carano, N. Primary carnitine deficiency dilated cardiomyopathy: 28 years follow-up. Int. J. Cardiol. 162, e34\u2013e35 (2013).","journal-title":"Int. J. Cardiol."},{"key":"50458_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10545-012-9488-8","volume":"36","author":"J Rasmussen","year":"2013","unstructured":"Rasmussen, J., Nielsen, O. W., Lund, A. M., K\u00f8ber, L. & Djurhuus, H. Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events. J. Inherit. Metab. Dis. 36, 35\u201341 (2013).","journal-title":"J. Inherit. Metab. Dis."},{"key":"50458_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00246-007-9051-9","volume":"29","author":"A Cano","year":"2008","unstructured":"Cano, A., Ovaert, C., Vianey-Saban, C. & Chabrol, B. Carnitine membrane transporter deficiency: a rare treatable cause of cardiomyopathy and anemia. Pediatr. Cardiol. 29, 163\u2013165 (2008).","journal-title":"Pediatr. Cardiol."},{"key":"50458_CR18","doi-asserted-by":"publisher","first-page":"s96","DOI":"10.1067\/mhj.2000.103921","volume":"139","author":"MEM Pierpont","year":"2000","unstructured":"Pierpont, M. E. M., Breningstall, G. N., Stanley, C. A. & Singh, A. Familial carnitine transporter defect: a treatable cause of cardiomyopathy in children. Am. Heart J. 139, s96\u2013s106 (2000).","journal-title":"Am. Heart J."},{"key":"50458_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/ajmg.10585","volume":"111","author":"AM Lamhonwah","year":"2002","unstructured":"Lamhonwah, A. M. et al. Novel OCTN2 mutations: no genotype\u2013phenotype correlations: early carnitine therapy prevents cardiomyopathy. Am. J. Med. Genet. 111, 271\u2013284 (2002).","journal-title":"Am. J. Med. Genet."},{"key":"50458_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/GIM.0b013e3181c5e6f7","volume":"12","author":"AW El-Hattab","year":"2010","unstructured":"El-Hattab, A. W. et al. Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. Genet. Med. 12, 19\u201324 (2010).","journal-title":"Genet. Med."},{"key":"50458_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1023\/A:1025968502527","volume":"26","author":"U Spiekerkoetter","year":"2003","unstructured":"Spiekerkoetter, U. et al. Silent and symptomatic primary carnitine deficiency within the same family due toidentical mutations in the organic cation\/carnitine transporter OCTN2. J. Inherit. Metab. Dis. 26, 613\u2013615 (2003).","journal-title":"J. Inherit. Metab. Dis."},{"key":"50458_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10545-013-9640-0","volume":"37","author":"J Rasmussen","year":"2014","unstructured":"Rasmussen, J., K\u00f8ber, L., Lund, A. M. & Nielsen, O. W. Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening. J. Inherit. Metab. Dis. 37, 223\u2013230 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"50458_CR23","first-page":"104","volume":"40","author":"RR Ascunce","year":"2013","unstructured":"Ascunce, R. R., Nayar, A. C., Phoon, C. K. & Srichai, M. B. Cardiac magnetic resonance findings in a case of carnitine deficiency. Tex. Heart Inst. J. 40, 104\u2013105 (2013).","journal-title":"Tex. Heart Inst. J."},{"key":"50458_CR24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","volume":"57","author":"L Iles","year":"2011","unstructured":"Iles, L. et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J. Am. Coll. Cardiol. 57, 821\u2013828, https:\/\/doi.org\/10.1016\/j.jacc.2010.06.062 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50458_CR25","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/CIRCULATIONAHA.104.529545","volume":"112","author":"JN Weiss","year":"2005","unstructured":"Weiss, J. N. et al. The dynamics of cardiac fibrillation. Circulation 112, 1232\u20131240, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.529545 (2005).","journal-title":"Circulation"},{"key":"50458_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/s0735-1097(98)00184-3","volume":"32","author":"T-J Wu","year":"1998","unstructured":"Wu, T.-J. et al. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. J. Am. Coll. Cardiol. 32, 187\u2013196, https:\/\/doi.org\/10.1016\/s0735-1097(98)00184-3 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50458_CR27","doi-asserted-by":"publisher","first-page":"H1594","DOI":"10.1152\/ajpheart.00579.2009","volume":"297","author":"N Morita","year":"2009","unstructured":"Morita, N. et al. Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 297, H1594\u20131605, https:\/\/doi.org\/10.1152\/ajpheart.00579.2009 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"50458_CR28","doi-asserted-by":"publisher","first-page":"H180","DOI":"10.1152\/ajpheart.00128.2011","volume":"301","author":"N Morita","year":"2011","unstructured":"Morita, N. et al. Glycolytic inhibition causes spontaneous ventricular fibrillation in aged hearts. Am. J. Physiol. Heart Circ. Physiol. 301, H180\u2013191, https:\/\/doi.org\/10.1152\/ajpheart.00128.2011 (2011).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"50458_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/CIRCRESAHA.107.160549","volume":"101","author":"M Miragoli","year":"2007","unstructured":"Miragoli, M., Salvarani, N. & Rohr, S. Myofibroblasts induce ectopic activity in cardiac tissue. Circ. Res. 101, 755\u2013758, https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.160549 (2007).","journal-title":"Circ. Res."},{"key":"50458_CR30","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/j.ejrad.2009.05.035","volume":"74","author":"M Spiewak","year":"2010","unstructured":"Spiewak, M. et al. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Eur. J. Radiol. 74, e149\u2013e153 (2010).","journal-title":"Eur. J. Radiol."},{"key":"50458_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1532-429x-14-51","volume":"14","author":"M Carlsson","year":"2012","unstructured":"Carlsson, M. et al. Cardiac output and cardiac index measured with cardiovascular magnetic resonance in healthy subjects, elite athletes and patients with congestive heart failure. J. Cardiovasc. Magn. Reson. 14, 51, https:\/\/doi.org\/10.1186\/1532-429x-14-51 (2012).","journal-title":"J. Cardiovasc. Magn. Reson."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50458-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50458-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50458-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:03:12Z","timestamp":1671285792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50458-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50458"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50458-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13909"}}